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AIT 　 　 　 　 　 　 　 　 　 　
Max area
(mm2)
0.36 <0.05 -0.12 0.38 -0.12 0.38 -0.13 0.31 -0.08 0.54
Total
length (mm)
0.42 <0.05 0.03 0.83 -0.16 0.22 -0.2 0.12 -0.14 0.29
Malapposed
area
　 　 　 　 　 　 　 　 　 　
Max area
(mm2)
-0.07 0.71 -0.16 0.22 0.15 0.25 0.04 0.76 0.8 <0.05
Total
length (mm)
-0.17 0.34 -0.17 0.2 0.34 <0.05 0.22 0.1 0.29 <0.05
Presence of
intra-stent
dissection
-0.16 0.35 0.09 0.62 -0.15 0.37 -0.2 0.24 0.06 0.73
Presence of
edge
dissection
-0.04 0.81 -0.11 0.4 0.02 0.86 0.16 0.23 0.15 0.27
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Background: Acute incomplete stent apposition (ISA) can occur at the time of stent
implantation. The mechanism underlying acute ISA seems to be related to procedural
technique, and additional balloon angioplasty is often performed to improve ISA. The
acute ISA might either resolve or persist at follow-up (late-persistent ISA). The aim of
this study was to evaluate the serial change of acute ISA after everolimus-eluting stent
(EES) compared with sirolimus-eluting stent (SES) between post-stenting and 10-
month follow-up by using optical coherence tomography (OCT).
Methods: Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting
stent Trial (RESET) is a prospective multicenter randomized open-label trial
comparing EES with SES in Japan. A total 77 (38EES, 39SES) patients who
underwent OCT in the RESET Trial between in post-stenting and 8-12 months follow-
up were enrolled in this study. We evaluated the serial change of acute ISA after EES
implantation compared with SES between post-stenting and follow-up by using OCT.
We measured maximum ISA distance, ISA cross sectional area (CSA), stent CSA at
maximum ISA site, and intra-stent lumen CSA.
Results: Of 38 ISA observed in EES at post-stenting (SES: 39), 28 (77%) ISA were
resolved (SES: 24[71%]). Although stent CSA did not change between post-stenting
and follow-up, intra-stent lumen CSA (EES: 6.81  1.66 mm2 vs. 6.02  1.72 mm2,
p<0.001, SES: 6.53  1.86 mm2 vs. 5.74  1.84 mm2, p<0.001), maximum ISA
distance (EES: 315 94 mmvs. 110 165 mm, p<0.001, SES: 306 118 mmvs. 139
194 mm, p<0.001), and ISACSA reduced (EES: 0.50 0.24mm2 vs. 0.17 0.27mm2,
p<0.001, SES: 0.94  0.69 mm2 vs. 0.40  0.65 mm2, p<0.001) signiﬁcantly during
10-month follow-up in EES and SES. Receiver operating characteristic curve analysis
showed that maximum ISA distance >355mm was the best cut-off value to predict
persistent ISA at 10-month follow-up (SES: maximum ISA distance > 285mm).
Conclusions: The stent with maximum ISA distance more than 355mm at post-
stenting in EES and 285mm in SES has a high risk for persistent ISA at 10-month
follow-up. OCT can predict persistent ISA and provide useful information to optimize
percutaneous coronary intervention.
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Background: Optical coherence tomography (OCT) can detect various types of vessel
reaction immediately after stent implantation, such as stent malapposition, thrombus,
prolapse, and dissection. The aim of this study was to assess how OCT ﬁndings after
stenting affect on peri-procedural myocardial enzyme leakage and vessel healing at 9-
month after everolimus-eluting stent (EES) implantation.
Methods: A total of 59 lesions in 48 patients treated with EES who underwent post
stenting and 9-month follow-up OCT were enrolled. Blood samples were drawn
before and 24 hours after index procedure to assess troponin I leakage. For the post
stenting analysis, quantitative assessment of abnormal intraluminal tissue (AIT)
formation inside of the stent, intra-stent dissection, edge dissection, and malapposed
area of the struts were performed. At 9-month, neointimal thickness, uncover and
malapposed strut, unevenness of neointima (neointima unevenness score: maximum /
average neointimal thickness) were calculated.B178 JACC Vol 62/18/Suppl B j October 27–NoveResults: AIT area and length immediately after stent implantation was positively
related to troponin I leakage at 24 hours, but not affected on 9-month OCT parameters.
The length of malapposed area measured by post procedure analysis was associated
with average neointima unevenness score and frequency of malapposed struts at 9-
month. The maximum malapposed area after stenting was associated with frequency
of malapposed struts at follow up. Intra-stent and edge dissection didn't affect either
troponin leak nor follow up OCT ﬁndings (Table).
Conclusions: Mass of AIT was positively related to troponin I leak, but not affected
on mid-term vessel healing. Strut malapposition was associated with insufﬁcient
vessel healings at 9-month.TCT-588
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Background: Suboptimal stent expansion is known to correlate with future adverse
cardiac events. BVS has less radial strength compared with metallic stents. With
increasing use of BVS it is important to understand its expansion characteristics. OCT
is an intravascular imaging modality that allows high resolution assessment of plaque
morphology, composition and stent expansion.
Methods: 12 patients with angina pectoris underwent OCT-guided BVS implan-
tation. All cross-sections of each BVS were analysed at 200mm longitudinal
intervals for lumen contours and plaque characteristics. Plaque type was divided
into ﬁbrous plaque (FP) or calciﬁc plaque (CP). Each pooled plaque characteristic
was divided into 2 groups based on the medians; FP area (0-4.0mm2,
>¼4.01mm2), FP thickness (0-0.79mm, >¼0.8mm), FP arc angle occupied (0-
184.2o, >184.3o), CP area (0-0.68mm2,>¼0.69mm2), CP thickness (0-0.48mm,
>¼0.49mm), CP arc angle (0-67.6o, >¼ 67.7o) and CP depth (0-0.19mm,
>¼0.2mm). Scaffold expansion index (SEI) was deﬁned as minimum scaffold
area/maximal area expressed as a percentage. Scaffold eccentricity (SE) was
deﬁned as minimum/maximum scaffold diameter. The relationship between each
plaque characteristic and SEI or SE was analysed by a repeated measures
ANOVA.
Results: 1381 frames totaling 273.4 mm of BVS were analysed. 28 ﬁbrous and 175
calciﬁc plaques were identiﬁed. A lower SEI was signiﬁcantly associated with higher
calciﬁc plaque area (average SEI 79.48% vs average SEI 81.87%, p<0.001), larger
CP arc angle (78.28% vs 83.08%, p<0.001) and lower CP depth (77.67% vs
83.42%, p<0.001). A lower SE was signiﬁcantly associated with a larger ﬁbrous
plaque area (0.84 vs 0.86, p<0.001), larger ﬁbrous plaque thickness (0.83 vs 0.86,
p<0.001), larger ﬁbrous plaque arc angle (0.84 vs 0.85, p<0.001), larger calcium
plaque area (0.83 vs 0.86, p< 0.001), higher calcium thickness (0.83 vs 0.86,
p<0.001), larger calcium angle (0.83 vs 0.86, p<0.001) and lower CP depth(0.84 vs
0.86, p<0.001).
Conclusions: Plaque composition, morphology and burden assessed by OCT
signiﬁcantly impacted on BVS expansion and eccentricity. These ﬁndings could have
clinical signiﬁcance and warrant further studies.mber 1, 2013 j TCT Abstracts/POSTER/Intravascular Imaging and PCI
